Log in

NASDAQ:AEMD - Aethlon Medical Stock Price, Forecast & News

$1.04
-0.95 (-47.74 %)
(As of 12/15/2019 02:15 AM ET)
Today's Range
$1.00
Now: $1.04
$1.12
50-Day Range
$1.00
MA: $3.14
$4.74
52-Week Range
$1.00
Now: $1.04
$25.65
Volume3.32 million shs
Average Volume40,943 shs
Market Capitalization$1.50 million
P/E RatioN/A
Dividend YieldN/A
Beta0.48
Aethlon Medical, Inc, a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals. It is also involved in the development of exosomal biomarkers to diagnose and monitor life-threatening disease conditions, such as cancer and neurological disorders; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection. Read More…

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AEMD
CUSIPN/A
Phone858-459-7800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$230,000.00
Book Value$1.82 per share

Profitability

Net Income$-6,200,000.00

Miscellaneous

Employees6
Market Cap$1.50 million
Next Earnings Date2/10/2020 (Estimated)
OptionableNot Optionable

Receive AEMD News and Ratings via Email

Sign-up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter.


Aethlon Medical (NASDAQ:AEMD) Frequently Asked Questions

What is Aethlon Medical's stock symbol?

Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD."

How were Aethlon Medical's earnings last quarter?

Aethlon Medical, Inc. (NASDAQ:AEMD) issued its quarterly earnings results on Friday, November, 1st. The medical equipment provider reported ($1.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.10) by $0.19. View Aethlon Medical's Earnings History.

When is Aethlon Medical's next earnings date?

Aethlon Medical is scheduled to release their next quarterly earnings announcement on Monday, February 10th 2020. View Earnings Estimates for Aethlon Medical.

Has Aethlon Medical been receiving favorable news coverage?

Headlines about AEMD stock have trended negative on Sunday, according to InfoTrie. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Aethlon Medical earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned media stories about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for Aethlon Medical.

Are investors shorting Aethlon Medical?

Aethlon Medical saw a increase in short interest during the month of November. As of November 29th, there was short interest totalling 22,100 shares, an increase of 160.0% from the November 14th total of 8,500 shares. Based on an average daily volume of 30,200 shares, the short-interest ratio is currently 0.7 days. Approximately 1.6% of the company's shares are sold short. View Aethlon Medical's Current Options Chain.

Who are some of Aethlon Medical's key competitors?

What other stocks do shareholders of Aethlon Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aethlon Medical investors own include Cytosorbents (CTSO), Novavax (NVAX), AT&T (T), Agile Therapeutics (AGRX), NewLink Genetics (NLNK), Ampliphi Biosciences (APHB), Ur-Energy (URG), Allena Pharmaceuticals (ALNA), Celldex Therapeutics (CLDX) and SCYNEXIS (SCYX).

Who are Aethlon Medical's key executives?

Aethlon Medical's management team includes the folowing people:
  • Mr. James B. Frakes, CFO, Sr. VP of Fin. & Sec. (Age 62)
  • Mr. James A. Joyce, Consultant (Age 57)
  • Dr. Timothy C. Rodell, Interim CEO & Director (Age 68)
  • Mr. Sunil Sawhney, Head of Clinical Studies
  • Dr. Richard H. Tullis, Consultant (Age 74)

Who are Aethlon Medical's major shareholders?

Aethlon Medical's stock is owned by many different of institutional and retail investors. Top institutional investors include Cordasco Financial Network (1.02%).

Which major investors are buying Aethlon Medical stock?

AEMD stock was purchased by a variety of institutional investors in the last quarter, including Cordasco Financial Network.

How do I buy shares of Aethlon Medical?

Shares of AEMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Aethlon Medical's stock price today?

One share of AEMD stock can currently be purchased for approximately $1.04.

How big of a company is Aethlon Medical?

Aethlon Medical has a market capitalization of $1.50 million and generates $230,000.00 in revenue each year. The medical equipment provider earns $-6,200,000.00 in net income (profit) each year or ($5.10) on an earnings per share basis. Aethlon Medical employs 6 workers across the globe.View Additional Information About Aethlon Medical.

What is Aethlon Medical's official website?

The official website for Aethlon Medical is http://www.aethlonmedical.com/.

How can I contact Aethlon Medical?

Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The medical equipment provider can be reached via phone at 858-459-7800 or via email at [email protected]


MarketBeat Community Rating for Aethlon Medical (NASDAQ AEMD)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  175 (Vote Outperform)
Underperform Votes:  156 (Vote Underperform)
Total Votes:  331
MarketBeat's community ratings are surveys of what our community members think about Aethlon Medical and other stocks. Vote "Outperform" if you believe AEMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AEMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel